HIPPO HOLDINGS INC

Insider Trading & Executive Data

HIPO
NYSE
Financial Services
Insurance - Specialty

Start Free Trial

Get the full insider signal for HIPO

63 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
63
7 in last 30 days
Buy / Sell (1Y)
22/41
Acquisitions / Dispositions
Unique Insiders (1Y)
16
Active in past year
Insider Positions
16
Current holdings
Position Status
15/1
Active / Exited
Institutional Holders
122
Latest quarter
Board Members
14

Compensation & Governance

Avg Total Compensation
$2.6M
Latest year: 2024
Executives Covered
7
Comp records available
Form 8-K Events (1Y)
2
Personnel Changes (1Y)
2
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
1
Board Appointments (1Y)
1
Board Departures (1Y)
1

Restricted Sales

Form 144 Filings (1Y)
20
Form 144 Insiders (1Y)
6
Planned Sale Shares (1Y)
623.7K
Planned Sale Value (1Y)
$17.4M
Price
$28.65
Market Cap
$739.8M
Volume
943
EPS
$3.77
Revenue
$120.6M
Employees
478
About HIPPO HOLDINGS INC

Company Overview

Hippo Holdings Inc. is an insurtech-focused insurance holding company operating three reportable segments: Services (consumer agency), Insurance-as-a-Service (Spinnaker acting as a fronting carrier that cedes most risk), and the Hippo Home Insurance Program (direct Hippo-branded homeowners coverage). The business mixes fee income, underwriting margin where it retains risk, and investment income on float, and differentiates via a full‑stack technology platform, proprietary underwriting/quoting engines and data-driven loss-prevention services. Management has tightened underwriting and reinsurance since mid‑2023 (higher retention on primary homeowners, selective proportional cover, XOL/cat bonds) and taken cost actions, producing material improvement in loss ratios, premium retention and adjusted EBITDA in 2024–H1 2025. The company is highly state‑regulated, sensitive to catastrophe seasonality, reinsurance capacity, reserve adequacy and capital/regulatory thresholds (e.g., Spinnaker’s >$500M DWP and related statutory capital actions).

Executive Compensation Practices

Compensation for Hippo executives is likely to emphasize insurance‑specific performance metrics in addition to traditional growth goals: underwriting profitability (loss ratios, combined ratio), net earned premium and premium retention, adjusted EBITDA or adjusted net income, and return on statutory capital given Spinnaker’s capital importance. Because Hippo is an insurtech, equity‑linked pay (stock awards, options, performance shares) and long‑term incentive plans are probable to retain key technical, data and underwriting talent while aligning incentives to rebuild underwriting discipline and ROE. Short‑term bonuses are likely tied to underwriting outcomes, reserve development and successful reinsurance negotiations or capital actions (e.g., surplus note issuance), and compensation committees will pay special attention to reserve/case‑development sensitivity given its material impact on results. Regulatory constraints (state holding‑company approval, ORSA/RBC outcomes) and potential future capital raises can also indirectly affect pay design, vesting, and dilution expectations.

Insider Trading Considerations

Insider trading activity at Hippo is likely influenced by the timing of material underwriting and capital events — e.g., quarterly reserve releases or adverse development, catastrophe seasons (wildfires, hurricanes), reinsurance treaty renewals, divestitures (First Connect sale) and capital transactions (surplus note, equity raises). Expect heightened insider selling following visible improvement in metrics (Q2 2025 GAAP net income and positive adjusted EBITDA) or after lock‑up/vesting events, while opportunistic buys may be rarer but could signal management conviction in continued underwriting recovery. Monitor Form 4 filings for option exercises and subsequent sales (common with growth‑stage public companies), clustered executive sales near period ends, and use of Rule 10b5‑1 plans; any sudden, large sales tied to reserve deterioration or capital needs should be treated as potential red flags. Finally, state insurance regulation and holding‑company approvals can impose blackout windows or additional disclosure expectations, increasing the informational value of the timing and magnitude of insider transactions.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for HIPPO HOLDINGS INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime